rs367619008
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3PP5
The NM_000110.4(DPYD):āc.187A>Gā(p.Lys63Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000031 in 1,613,648 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K63N) has been classified as Uncertain significance.
Frequency
Consequence
NM_000110.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DPYD | NM_000110.4 | c.187A>G | p.Lys63Glu | missense_variant | 3/23 | ENST00000370192.8 | NP_000101.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DPYD | ENST00000370192.8 | c.187A>G | p.Lys63Glu | missense_variant | 3/23 | 1 | NM_000110.4 | ENSP00000359211.3 | ||
DPYD | ENST00000306031.5 | c.187A>G | p.Lys63Glu | missense_variant | 3/6 | 1 | ENSP00000307107.5 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250872Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135592
GnomAD4 exome AF: 0.0000308 AC: 45AN: 1461442Hom.: 0 Cov.: 31 AF XY: 0.0000289 AC XY: 21AN XY: 727006
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74352
ClinVar
Submissions by phenotype
Dihydropyrimidine dehydrogenase deficiency Pathogenic:2Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 08, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Nov 14, 2017 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 18, 2022 | Variant summary: DPYD c.187A>G (p.Lys63Glu) results in a conservative amino acid change located in the Dihydroprymidine dehydrogenase domain II (IPR028261) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.2e-05 in 250872 control chromosomes. c.187A>G has been reported in the literature as a compound heterozygous genotype with this variant and the classical DPYD*2A allele in at-least one individual affected with classical features of autosomal recessive Dihydropyrimidine Dehydrogenase Deficiency (example, Weidensee_2011) and has also been reported in individuals experiencing high toxicity to fluoropyramidines (example, Kleibl_2009). At least one publication reports experimental evidence evaluating an impact on protein function (example, Shreshta_2018). The most pronounced variant effect results in <10% of normal in-vitro DPYD activity. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 13, 2024 | Published functional studies demonstrate a damaging effect on DPD activity (PMID: 29327356); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34426522, 21420945, 36678742, 34959317, 19473056, 29327356) - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 21, 2022 | The c.187A>G (p.K63E) alteration is located in exon 3 (coding exon 3) of the DPYD gene. This alteration results from a A to G substitution at nucleotide position 187, causing the lysine (K) at amino acid position 63 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at